Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shifeng Li

Showing results (151-160 of 152) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 152 results.
Immunology|July 7, 2022
E3 ubiquitin ligase MID1 ubiquitinates and degrades type-I interferon receptor 2Xiangjie Chen, Qian Zhao, Ying Xu, et al.
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.
Pageof 16

Showing results (151-160 of 152) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 152 results.
Immunology|July 7, 2022
E3 ubiquitin ligase MID1 ubiquitinates and degrades type-I interferon receptor 2Xiangjie Chen, Qian Zhao, Ying Xu, et al.
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.
Pageof 16